FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) Building world’s largest indoor cannabis grower.

November 13, 2018 admin CEO Interview, Consumer, Healthcare, Spotlight Stocks Comments Off on FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) Building world’s largest indoor cannabis grower.

 

 

 

 

Dr. Raza Bokhari, CEO FSD Pharma

 

 

 

 

 

 

FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) CEO Interview with Dr. Raza Bokhari.  FSD Pharma is building the worlds largest licensed indoor cannabis growing facility in the world, located in Coburg, Ontario, Canada. We caught up with Dr. Bokhari as he was driving to the airport for his flight to Tel Aviv to wrap up the Therapix Topics discussed:

  1. Progress update on Coburg production facility (expected to start delivering cannabis in Q1 2019), which is expected to be one of the largest, and most cost-efficient indoor growers of cannabis.
  2. FSD Pharma’s competitive advantages.
  3. Therapix Biosciences acquisition
  4. Expanding leadership team for increasing focus on medical cannabis
  5. Progress towards NASDAQ listing

INVESTOR PRESENTATION

FSD-Pharma-Investor-Deck-October-2018-V8
Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.




Related Articles

Newsmakers

Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

May 5, 2018 admin Newsmakers Comments Off on Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

ISFIYA, Israel, May 04, 2018 — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, […]

Healthcare

CytoDyn (OTC: CYDY) Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

December 17, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

VANCOUVER, Washington and NEW YORK, Dec 17, 2019 – In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, Vyera will pay upfront and regulatory and sales-based milestone […]

Healthcare

FSD Pharma Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint

November 14, 2018 admin Healthcare, Newsmakers Comments Off on FSD Pharma Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint

TORONTO, Nov. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company“) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) under the […]